Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
What Is a Patient Advocate, and Does Your Family Need One?
Thinning Retinas Offer A Clue To Early Alzheimer’s Diagnosis
The First Signs of Dementia, Or Just Normal Aging?
Dementia Caregivers, Coronavirus, and Turning a Burden Into a Journey of Personal Growth
Words Matter: Changing the Way We Talked About Alzheimer’s Changed My Dad’s Experience for the Better
Could AI Testing Replace Doctors in Alzheimer’s Prediction and Diagnosis?
Phil’s Journal: ‘Caring Places,’ or, a Meditation on the Future of Long-Term Care Facilities
Coronavirus: Telemedicine Is Not a Panacea
A Closer Look At How Viruses May Spur Alzheimer’s
Coronavirus: More Than Ever, Dementia Caregivers Are Turning to iPads in Eldercare
As COVID Devastates Nursing Homes, Here’s How One Has Kept Its Residents Safe
A New Drug for Agitation in Alzheimer’s Progresses Through Trials
Robotic Pets Keep Older Adults Company During COVID Lockdown
Seaweed Alzheimer’s Drug Approved for U.S. Clinical Trials — First New Drug in 17 years
Euthanasia For Dementia Allowed by European Court
Previous
99
100
101
Next
Page load link
Go to Top